Newsfeeds - Spark Newswire

3 minute read

Mid-Morning Market Update: Markets Open Lower; US Initial Jobless Claims Drop To 52-Year Low

Today, 10:32 AM

Following the market opening Thursday, the Dow traded down 0.22% to 35,676.45 while the NASDAQ fell 0.30% to 15,740.38. The S&P also fell, dropping 0.21% to 4,691.18.

AMAM

1 minute read

Goldman Sachs Downgrades Reata Pharmaceuticals to Neutral, Announces $39 Price Target

By Benzinga Newsdesk

Today, 10:32 AM

Goldman Sachs analyst Salveen Richter downgrades Reata Pharmaceuticals (NASDAQ:RETA) from Buy to Neutral and announces $39 price target.

RETA

4 minute read

The Daily Biotech Pulse: Reata Plunges On Adcom Snub, AstraZeneca Antibody Cocktail Authorized For COVID-19 Prevention, NeuroSense IPO

By Shanthi Rexaline

Today, 10:32 AM

Here's a roundup of top developments in the biotech space over the last 24 hours:

AMAM

2 minute read

21 Stocks Moving in Thursday’s Pre-Market Session

By Lisa Levin

Today, 10:32 AM

Gainers Pear Therapeutics, Inc. (NASDAQ: PEAR) rose 64% to $15.20 in pre-market trading after climbing around 16% on Wednesday.

AVCT

1 minute read

Cantor Fitzgerald Maintains Overweight on Reata Pharmaceuticals, Lowers Price Target to $68

By Benzinga Newsdesk

Today, 10:32 AM

Cantor Fitzgerald analyst Charles Duncan maintains Reata Pharmaceuticals (NASDAQ:RETA) with a Overweight and lowers the price target from $112 to $68.

RETA

1 minute read

Baird Downgrades Reata Pharmaceuticals to Neutral, Lowers Price Target to $37

By Benzinga Newsdesk

Today, 10:32 AM

Baird analyst Brian Skorney downgrades Reata Pharmaceuticals (NASDAQ:RETA) from Outperform to Neutral and lowers the price target from $110 to $37.

RETA

1 minute read

FDA
News

Reata Pharmaceuticals Announces Outcome Of FDA Advisory Committee Meeting Of Bardoxolone For Treatment Of Patients With Chronic Kidney Disease Caused By Alport Syndrome; Says Committee Voted ‘No’ On Effective Question

By Benzinga Newsdesk

Today, 10:32 AM

Reata Pharmaceuticals, Inc. (NASDAQ:RETA) ("Reata," the "Company," or "we"), today announced the outcome of the U.S. Food and Drug Administration ("FDA") Cardiovascular and Renal

RETA

3 minute read

36 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

Today, 10:32 AM

Gainers

ACET

3 minute read

Mid-Morning Market Update: Markets Mostly Higher; Science Applications International Posts Upbeat Earnings

By Lisa Levin

Today, 10:32 AM

Following the market opening Monday, the Dow traded up 1.35% to 35,048.01 while the NASDAQ fell 0.17% to 15,059.43. The S&P also rose, gaining 0.59% to 4,565.21.

ACET